Liver Cirrhosis
600
65
82
216
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
37 trials with published results (6%)
Research Maturity
216 completed trials (36% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
6.3%
38 terminated out of 600 trials
85.0%
-1.5% vs benchmark
13%
80 trials in Phase 3/4
17%
37 of 216 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 216 completed trials
Clinical Trials (600)
A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic Encephalopathy
Electronic PHES vs Paper-based PHES for Hepatic Encephalopathy
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
National Liver Cancer Screening Trial
Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)
Safety and Adequacy of Trans-jugular Liver Biopsy in Patients With Liver Disease: SAFE-TJLB Study
A Novel Extracorporeal Liver Support Therapy In ALCF and to Evaluate the Efficacy of DIALIVE 2.0, a Liver Dialysis Device.
Daridorexant for Sleep Disturbance in Adults With Liver Cirrhosis
Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver Cirrhosis
Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome (COMBAT Trial).
Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis
Effect of Laparoscopic Hepatectomy Combined With Splenectomy on Hepatic Functional Reserve and Immune Function
Colonic Polypectomy in Cirrhotic Patients With Portal Hypertension
Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS
Hypothyroidism and Liver Fibrosis Severity in MASLD
Terlipressin vs. Somatostatin in Cirrhotic Patients With Acute Variceal Bleeding and Renal Dysfunction
Application of Different Scores in Predicting Outcomes of Cirrhotic Patients Awaiting Liver Transplantation
Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis